Poeta et al. found that disruptive p53 mutations, defined as resulting in an early stop codon or an alteration in the critical DNA binding domain of p53, were associated with worse survival in head and neck squamous cell carcinoma [16]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.